Skip to main content

Table 1 Analysis of the available late blastocysts from different cleavage stages on different days and expansion stages

From: The impact of clinical and laboratory parameters on clinical pregnancy and live birth rates in fresh cycles: a retrospective study of 9608 high-quality cleavage-stage embryos

Variable

Day 5, n (%)

Day 6, n (%)

Pa

Same cell numbers

group 811

  

1808 (74.46)

620 (25.54)

0.891

 

expansion stage ≥ 4

1286 (71.13)

  

0.018

 

expansion stage < 4

522 (28.87)

   

group 821

  

1245 (73.80)

442 (26.20)

 
 

expansion stage ≥ 4

826 (66.35)

   
 

expansion stage < 4

419 (33.65)

   

group 812

  

723 (74.23)

251 (25.77)

 
 

expansion stage ≥ 4

505 (69.85)

   
 

expansion stage < 4

218 (30.15)

   

Different cell numbers

group 811

  

1808 (74.46)

620 (25.54)

< 0.001

 

expansion stage ≥ 4

1286 (71.13)

  

0.001

 

expansion stage < 4

522 (28.87)

   

group 711

  

271 (55.88)

214 (44.12)

 
 

expansion stage ≥ 4

165 (60.89)

   
 

expansion stage < 4

106 (39.11)

   

group 911

  

227 (75.42)

74 (24.58)

 
 

expansion stage ≥ 4

167 (73.57)

   
 

expansion stage < 4

60 (26.43)

   
  1. a Kruskal-Wallis test